Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
79
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Clene Inc market cap is $50.4M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Clene Inc 52 week high is $10.84 as of November 20, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Clene Inc 52 week low is $3.02 as of November 20, 2026.
Clene Inc stock price today is $3.52.
Clene Inc stock price yesterday was $3.50.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Clene Inc's P/E ratio is -1.34.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Clene Inc P/B ratio is -3.3596.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Clene Inc 50-day moving average is $3.87.